Video Experimental Relacionado

Updated: Feb 23, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

DNMT2 inhibe la progresión del cáncer de tiroides anaplásico mediante la regulación a la baja de la producción de

Ruixin Zhou^1,2, Baizhao Li^1,2, Mingyu Cao^1,2

¹Department of General Surgery, Xiangya Hospital of Central South University, Changsha, Hunan, China.

Cell death & disease

|February 21, 2026

Resumen

La reducción de la expresión de la ADN metiltransferasa 2 (DNMT2) promueve el carcinoma de tiroides anaplásico (ATC) mediante el aumento del 5'tiRNA ^Gly-GCC. Esta molécula se dirige a hnRNPH1, lo que impulsa la progresión del tumor. La inhibición del 5'tiRNA ^Gly-GCC muestra un potencial terapéutico para el ATC.

Área de la Ciencia:

Biología Molecular Biología Molecular
Investigación de Investigación del Cáncer.
La epigenética es la epigenética.

Sus antecedentes:

Las modificaciones del ARN de transferencia (ARNt) son cruciales para la función e integridad celular.
La ADN metiltransferasa 2 (DNMT2) juega un papel en la metilación del tRNA m5C, influyendo en la progresión del cáncer.
Los mecanismos específicos que vinculan DNMT2, la metilación del tRNA y el desarrollo tumoral no se comprenden completamente.

Objetivo del estudio:

Para investigar el papel de DNMT2 en la progresión del carcinoma de tiroides anaplásico (ATC).
Para dilucidar los mecanismos moleculares por los cuales DNMT2 afecta el desarrollo del tumor a través de la metilación del tRNA.
Para identificar posibles objetivos terapéuticos para el tratamiento de ATC.

Principales métodos:

Análisis de la expresión de DNMT2 en ATC.
Identificación de los sitios de metilación de m5C mediados por DNMT2 en tRNAs específicos (tRNA-Asp-GUC, tRNA-Gly-GCC, tRNA-Val-AAC).
Investigación de la generación de 5'tiRNA^Gly-GCC y su interacción con hnRNPH1.
Estudios in vivo en los que se utilizó un inhibidor del 5'tiRNA ^Gly-GCC y el clorhidrato de doxorubicina.

Principales resultados:

Se encontró que la expresión reducida de DNMT2 promueve la progresión de la ATC.
DNMT2 cataliza la metilación de m5C38 en tRNAs específicos en el ATC.
La pérdida de DNMT2 conduce a un aumento de la abundancia de 5'tiRNA ^Gly-GCC a través de la escisión mediada por ANG.
5'tiRNA^Gly-GCC se une a hnRNPH1, reduciendo sus niveles de proteína.
La inhibición combinada de 5'tiRNA ^Gly-GCC y el clorhidrato de doxorubicina suprimió la progresión de la ATC in vivo.

Conclusiones:

La disminución de la expresión de DNMT2 facilita el desarrollo de ATC al promover la producción de 5'tiRNA ^Gly-GCC.
El eje 5'tiRNA^Gly-GCC/hnRNPH1 es un mecanismo clave en la progresión de la ATC.
Dirigirse al 5'tiRNA ^Gly-GCC presenta una estrategia terapéutica prometedora para el ATC.

Más Videos Relacionados

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

Videos de Conceptos Relacionados

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

The Nucleolus

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...